Assessment of Medication Adherence in Ccu Admitted Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAlFayhaa General Hospital
About this trial
This study aims to assess medication adherence and the appropriateness of prescribed medications among patients admitted to the Coronary Care Unit (CCU). The study will use the Medication Appropriateness Index (MAI) to evaluate the suitability of prescribed medications and the Beliefs about Medicines Questionnaire (BMQ) to assess patients' beliefs and perceptions regarding their medications. Understanding medication adherence and related beliefs may help identify factors associated with inappropriate medication use and non-adherence in hospitalized cardiac patients. The findings of this study may contribute to improving medication management and patient care in the CCU setting.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients aged 18 years or older
Diagnosed with atrial fibrillation or heart failure
Admitted to the coronary care unit
Clinically stable at the time of interview
Disqualifiers
Significant cognitive impairment
Communication difficulties preventing interview
Diagnosed psychiatric disorder interfering with participation
Trial population
Adult patients aged 18 years or older diagnosed with atrial fibrillation or heart failure who are admitted to the coronary care unit. Participants will be clinically stable at the time of assessment and able to provide informed consent.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
No intervention (observational study)
Other interventionThis is an observational study with no active intervention.
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: CCU HF and AF Patients1 intervention
Trial outcomes
Primary outcomes
1
Medication adherence (BMQ)
Medication adherence will be assessed using the Brief Medication Questionnaire (BMQ), a validated tool that evaluates medication-taking behavior and barriers to adherence.
Time frame
During CCU admission after clinical stabilization (assessed up to 5 days)2
Medication appropriateness measured by Medication Appropriateness Index (MAI)
Medication appropriateness will be assessed using the Medication Appropriateness Index (MAI). The MAI score ranges from 0 to 12, where lower scores indicate better medication adherence and higher scores indicate poorer adherence.
Time frame
During CCU admission after clinical stabilization (assessed up to 5 days)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: